2,894 articles

The anticancer activity and mechanisms of She medicine herbs

in Pharmacology of Anti-Cancer Drugs

• Yunxuan Miao
• Yisheng Chen
• Miao Wang
• Qiaofen Lan
• Runqiong Chen
• Ruogu Chen
• Jiajia Zhuang
• Haojun Shi
• Jianzhong Xiao
• Chengshou Lin

Autophagy inhibition induced by EM-2 augments apoptosis via ROS-mediated ATM-Chk2-p53-p21 and MAPK pathway in lung and breast carcinoma

in Pharmacology of Anti-Cancer Drugs

• Jinxia Cheng
• Ying Chen
• Qi Chen
• Ning Cao
• Chuyu He
• Yanjun Xu
• Xiaoying Zhang
• Qiang Li
• Hong Hong
• Jianwei Jiang

Identification of an Ara-C resistance-related gene risk score and the role of S100A4 in AML via NR6A1-dependent activation and p53 regulation

in Pharmacology of Anti-Cancer Drugs

• Li Wang
• Aoshuang Huang
• Bingqing Cheng
• Xiuying Hu
• Jishi Wang

Mechanistic Insights and Anti-cancer Activity of 2H-benzo[b][1,4]oxazin-3(4H)-one Linked 1,2,3-Triazoles in Human Cancer Cells

in Pharmacology of Anti-Cancer Drugs

• Qingying Liu
• Xixi Hou
• Mingyue Tian
• Baoyu He
• Jingjing Guo
• Yajie Guo
• Jianxue Yang

Engineered immune cell therapies for solid tumors: pharmacological advances, clinical outcomes, and future directions

in Pharmacology of Anti-Cancer Drugs

• Ziyad M. Althafar

Retraction: Polyphenolic fraction obtained from Thalassia testudinum marine plant and thalassiolin B exert cytotoxic effects in colorectal cancer cells and arrest tumor progression in a xenograft mouse model

in Pharmacology of Anti-Cancer Drugs

Ginsenosides Rh2 and Rg3 exert their anti-cancer effects on non-small cell lung cancer by regulating cell autophagy and choline-phosphatidylcholine metabolism

in Pharmacology of Anti-Cancer Drugs

• Zhao Min
• Che Er-Xi
• Wang Lin-Juan
• Wang Lin
• Liu Bi-Li
• Chen Qiu-Fang

Licochalcone A suppresses pancreatic ductal adenocarcinoma progression by targeting eEF2K-mediated pyroptosis

in Pharmacology of Anti-Cancer Drugs

• Junjie Peng
• Hiutung Chan
• Wenqing Chen
• Ken Kin-Lam Yung
• King-Ho Cheung
• Zhu Zhang

Tiragolumab and TIGIT: pioneering the next era of cancer immunotherapy

in Pharmacology of Anti-Cancer Drugs

• Kosar Ghasemi

Retraction: Eupalinolide J suppresses the growth of triple-negative breast cancer cells via targeting STAT3 signaling pathway

in Pharmacology of Anti-Cancer Drugs

The supporting role of Schwann cells in perineural invasion of pancreatic ductal adenocarcinoma

in Pharmacology of Anti-Cancer Drugs

• Yun He
• Zheng Chen
• Liu Yang
• Shuanying Qiao
• Zonghua Su
• Feng Ding
• Fadian Ding
• Fuli Xin
• Siyu Xiang
• Aiping Lyu

Efficacy and safety of immunotherapy or antiangiogenic agent-based treatment strategies versus chemotherapy as first-line treatment for extensive-stage small cell lung cancer: a network meta-analysis

in Pharmacology of Anti-Cancer Drugs

• Chengjun Wang
• Chuang Yang
• Wen Zhao
• Rongyu Zhang
• Tiantian Xuan
• Jisheng Li

An integrated approach based on FDA adverse event reporting system, network pharmacology, molecular docking, and molecular dynamics simulation analysis to study the cardiac adverse reactions and mechanism of action of osimertinib

in Pharmacology of Anti-Cancer Drugs

• Wenjuan Wang
• Hong Liu
• Yongqing Wen
• Yanhua Zhang
• Xu Ma

Structure-based molecular screening and dynamic simulation of phytocompounds targeting VEGFR-2: a novel therapeutic approach for papillary thyroid carcinoma

in Pharmacology of Anti-Cancer Drugs

• Shuai Wang
• Lingqian Zhang
• Wenjun Zhang
• Xiong Zeng
• Jie Mei
• Weidong Xiao
• Lijie Yang

The type I ribosome-inactivating protein α-MMC induced significant apoptosis of lung cancer A549 and 95-D cells by activating the caspase cascade through TNF signaling pathway

in Pharmacology of Anti-Cancer Drugs

• Di Yang
• Di Peng
• Houke Li
• Di Jia
• Yiping Zhou
• Bintao Hu
• Wei Chen
• Yao Meng

Case Report: Osimertinib-induced acute interstitial lung disease

in Pharmacology of Anti-Cancer Drugs

• Zhiwu Lin
• Liang Wu
• Yang Yu
• Jiudong Jiang
• Yanchun Yang
• Guibao Xiao